Efficacy of EA575 as an Antitussive and Mucoactive Agent in Preclinical In Vivo Models
<b>Background:</b> The efficacy of EA575 in the treatment of respiratory diseases is described in various clinical studies, improving patients’ disease-related symptoms. However, mechanistic in vivo data proving its beneficial effects are limited. <b>Methods:</b> Focusing on...
Saved in:
| Main Authors: | Matthias Hufnagel, André Rademaekers, Anika Weisert, Hanns Häberlein, Sebastian Franken |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/7/1673 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of a Single Ivy Extract Versus Two Herbal Extract Combinations in Patients with Acute Bronchitis: A Multi-Center, Randomized, Open-Label Clinical Trial
by: Peter Kardos, et al.
Published: (2025-05-01) -
Mucoactive cough therapy: what is behind the horizon?
by: A. A. Zaitsev
Published: (2021-06-01) -
Use of antitussive medications in acute cough in young children
by: Samuel H. F. Lam, et al.
Published: (2021-06-01) -
Approaches to the diagnosis and therapy of cough in therapeutic practice
by: D. S. Sukhanov, et al.
Published: (2023-07-01) -
The Impact of Ivy Leaf Dry Extract EA 575 on Subsequent Antibiotic Use and Its Therapeutic Value in Children and Adolescents with the Common Cold: A Retrospective Prescription Database Analysis
by: Christian Vogelberg, et al.
Published: (2025-04-01)